Search Results 961-970 of 18991 for Neutrophil

  1. A Trial of RAdium-223 and SABR Versus SABR for oligomEtastatic Prostate caNcerS (RAVENS) - Mayo Clinic

    Participation eligibility · Before the first administration of Xofigo, the absolute neutrophil count (ANC) should be ≥ 1.5 x 10^9/L; · The platelet count ≥ 100 ...

  2. Safety and Efficacy Study of PRI-724 in Subjects With Advanced Solid Tumors - Mayo Clinic

    Absolute neutrophil count (ANC) > 1,500/µL - Platelet count> 100,000/µL. Patients must have adequate renal function as evidenced by a serum creatinine value ...

  3. Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive Craniopharyngioma - Mayo Clinic

    Absolute neutrophil count >= 1500/mm^3; Platelets >= 100,000/mm^3; Creatinine =< 1.5 mg/dL OR creatinine clearance >= 45mL/min; Bilirubin =< 1.5 upper limit of ...

  4. Cisplatin and Gemcitabine Hydrochloride With or Without ATR Kinase Inhibitor VX-970 in Treating Patients With Metastatic Urothelial Cancer - Mayo Clinic

    Absolute neutrophil count ≥ 1,500/mcL; Platelets ≥ 100,000/mcL; Total bilirubin within normal institutional limits; Aspartate aminotransferase (AST) (serum ...

  5. A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene Alterations - Mayo Clinic

    Absolute neutrophil count (ANC) ≥ 1000/mm^3 (1.0 x 10^9 /L);; Platelet count ≥ 75,000/ mm^3 (75x 10^9 /L);; • Hemoglobin ≥ 9.0 g/dL (at least 7 days since ...

  6. Clinical trials - Oncology (Medical)

    MC1733, Phase I Trial of Intratumoral Administration of a Measles Virus Derivative Expressing the Helicobacter pylori Neutrophil-activating Protein (NAP) ...

  7. Non-Alcoholic Fatty Liver Disease Progression Prevention Using Lisinopril - Mayo Clinic

    - Absolute neutrophil count ≥ 1,500/microliter. - Platelets ≥ 75,000/microliter. - Total bilirubin within normal institutional limits unless the patient ...

  8. Clinical trials - Oncology (Medical)

    MC1733, Phase I Trial of Intratumoral Administration of a Measles Virus Derivative Expressing the Helicobacter pylori Neutrophil-activating Protein (NAP) ...

  9. Phase 1 Study to Evaluate the Safety of ATA188 in Subjects With Progressive and Relapsing-Remitting Multiple Sclerosis - Mayo Clinic

    Hemoglobin < 10 g/dL; platelet < 100×109/L; absolute neutrophil count < 1.5×109/L. Any contraindication to MRI and/or Gd, eg, any object that is reactive to ...

  10. Veliparib and Topotecan Hydrochloride in Treating Patients with Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer - Mayo Clinic

    Absolute neutrophil count ≥ 1500/mcL; Hemoglobin ≥ 9.0 g/dL; Platelets ≥ 100,000/mcL; Total bilirubin ≤ 1.5x the upper limit of normal (ULN); Serum glutamic ...